Cargando…
Response: Increased Risk of Hospitalization for Heart Failure with Newly Prescribed Dipeptidyl Peptidase-4 Inhibitors and Pioglitazone Using the Korean Health Insurance Claims Database (Diabetes Metab J 2015;39:247-52)
| Autores principales: | , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Korean Diabetes Association
2015
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4543201/ https://www.ncbi.nlm.nih.gov/pubmed/26301199 http://dx.doi.org/10.4093/dmj.2015.39.4.350 |
| _version_ | 1782386584677515264 |
|---|---|
| author | Suh, Sunghwan Seo, Gi Hyeon Jung, Chang Hee Kim, Mee-Kyoung Jin, Sang-Man Hwang, You-Cheol Lee, Byung-Wan Kim, Jae Hyeon |
| author_facet | Suh, Sunghwan Seo, Gi Hyeon Jung, Chang Hee Kim, Mee-Kyoung Jin, Sang-Man Hwang, You-Cheol Lee, Byung-Wan Kim, Jae Hyeon |
| author_sort | Suh, Sunghwan |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-4543201 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2015 |
| publisher | Korean Diabetes Association |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-45432012015-08-21 Response: Increased Risk of Hospitalization for Heart Failure with Newly Prescribed Dipeptidyl Peptidase-4 Inhibitors and Pioglitazone Using the Korean Health Insurance Claims Database (Diabetes Metab J 2015;39:247-52) Suh, Sunghwan Seo, Gi Hyeon Jung, Chang Hee Kim, Mee-Kyoung Jin, Sang-Man Hwang, You-Cheol Lee, Byung-Wan Kim, Jae Hyeon Diabetes Metab J Response Korean Diabetes Association 2015-08 2015-08-17 /pmc/articles/PMC4543201/ /pubmed/26301199 http://dx.doi.org/10.4093/dmj.2015.39.4.350 Text en Copyright © 2015 Korean Diabetes Association http://creativecommons.org/licenses/by-nc/3.0/ This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited. |
| spellingShingle | Response Suh, Sunghwan Seo, Gi Hyeon Jung, Chang Hee Kim, Mee-Kyoung Jin, Sang-Man Hwang, You-Cheol Lee, Byung-Wan Kim, Jae Hyeon Response: Increased Risk of Hospitalization for Heart Failure with Newly Prescribed Dipeptidyl Peptidase-4 Inhibitors and Pioglitazone Using the Korean Health Insurance Claims Database (Diabetes Metab J 2015;39:247-52) |
| title | Response: Increased Risk of Hospitalization for Heart Failure with Newly Prescribed Dipeptidyl Peptidase-4 Inhibitors and Pioglitazone Using the Korean Health Insurance Claims Database (Diabetes Metab J 2015;39:247-52) |
| title_full | Response: Increased Risk of Hospitalization for Heart Failure with Newly Prescribed Dipeptidyl Peptidase-4 Inhibitors and Pioglitazone Using the Korean Health Insurance Claims Database (Diabetes Metab J 2015;39:247-52) |
| title_fullStr | Response: Increased Risk of Hospitalization for Heart Failure with Newly Prescribed Dipeptidyl Peptidase-4 Inhibitors and Pioglitazone Using the Korean Health Insurance Claims Database (Diabetes Metab J 2015;39:247-52) |
| title_full_unstemmed | Response: Increased Risk of Hospitalization for Heart Failure with Newly Prescribed Dipeptidyl Peptidase-4 Inhibitors and Pioglitazone Using the Korean Health Insurance Claims Database (Diabetes Metab J 2015;39:247-52) |
| title_short | Response: Increased Risk of Hospitalization for Heart Failure with Newly Prescribed Dipeptidyl Peptidase-4 Inhibitors and Pioglitazone Using the Korean Health Insurance Claims Database (Diabetes Metab J 2015;39:247-52) |
| title_sort | response: increased risk of hospitalization for heart failure with newly prescribed dipeptidyl peptidase-4 inhibitors and pioglitazone using the korean health insurance claims database (diabetes metab j 2015;39:247-52) |
| topic | Response |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4543201/ https://www.ncbi.nlm.nih.gov/pubmed/26301199 http://dx.doi.org/10.4093/dmj.2015.39.4.350 |
| work_keys_str_mv | AT suhsunghwan responseincreasedriskofhospitalizationforheartfailurewithnewlyprescribeddipeptidylpeptidase4inhibitorsandpioglitazoneusingthekoreanhealthinsuranceclaimsdatabasediabetesmetabj20153924752 AT seogihyeon responseincreasedriskofhospitalizationforheartfailurewithnewlyprescribeddipeptidylpeptidase4inhibitorsandpioglitazoneusingthekoreanhealthinsuranceclaimsdatabasediabetesmetabj20153924752 AT jungchanghee responseincreasedriskofhospitalizationforheartfailurewithnewlyprescribeddipeptidylpeptidase4inhibitorsandpioglitazoneusingthekoreanhealthinsuranceclaimsdatabasediabetesmetabj20153924752 AT kimmeekyoung responseincreasedriskofhospitalizationforheartfailurewithnewlyprescribeddipeptidylpeptidase4inhibitorsandpioglitazoneusingthekoreanhealthinsuranceclaimsdatabasediabetesmetabj20153924752 AT jinsangman responseincreasedriskofhospitalizationforheartfailurewithnewlyprescribeddipeptidylpeptidase4inhibitorsandpioglitazoneusingthekoreanhealthinsuranceclaimsdatabasediabetesmetabj20153924752 AT hwangyoucheol responseincreasedriskofhospitalizationforheartfailurewithnewlyprescribeddipeptidylpeptidase4inhibitorsandpioglitazoneusingthekoreanhealthinsuranceclaimsdatabasediabetesmetabj20153924752 AT leebyungwan responseincreasedriskofhospitalizationforheartfailurewithnewlyprescribeddipeptidylpeptidase4inhibitorsandpioglitazoneusingthekoreanhealthinsuranceclaimsdatabasediabetesmetabj20153924752 AT kimjaehyeon responseincreasedriskofhospitalizationforheartfailurewithnewlyprescribeddipeptidylpeptidase4inhibitorsandpioglitazoneusingthekoreanhealthinsuranceclaimsdatabasediabetesmetabj20153924752 |